Cooper LJ, Ausubel L, Gutierrez M, Stephan S, Shakeley R, Olivares S, Serrano LM, Burton L, Jensen MC, Forman SJ, DiGiusto DL, DiGiusto DL. Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma. Cytotherapy; 2006, 8(2): 105-117.
Han CH, Liu A, Schultheiss TE, Pezner RD, Chen YJ, Wong JY. Dosimetric comparisons of helical tomotherapy treatment plans and step-and-shoot intensity-modulated radiosurgery treatment plans in intracranl stereotactic radiosurgery. International Journal of Radiation Oncology Biology Physics; 2006, 65(2): 608-616.
Johnson LE, Frye TP, Arnot AR, Marquette C, Couture LA, Gendron FA, McNeel DG. Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP). Vaccine; 2006, 24(3): 293-303.
Li CX, Kato M, Shiue L, Shively JE, Ares M, Lin RJ. Cell type and culture condition-dependent alternative splicing in human breast cancer cells revealed by splicing-sensitive microarrays. Cancer Research; 2006, 66(4): 1990-1999.
Li L, Yazaki PJ, Anderson AL, Crow D, Colcher D, Wu AM, Williams LE, Wong JY, Raubitschek A, Shively JE. Improved biodistribution and radioimmunoimaging with poly(ethylene glycol)-DOTA-conjugated anti-CEA diabody. Bioconjugate Chemistry; 2006, 17(1): 68-76.
Madsen MT, Anderson JA, Halama JR, Kleck J, Simpkin DJ, Votaw JR, Wendt RE, Williams LE, Yester MV. AAPM task group 108: PET and PET/CT shielding requirements. Medical Physics; 2006, 33(1): 4-15.
Serrano LM, Pfeiffer T, Olivares S, Numbenjapon T, Bennitt J, Kim D, Smith D, McNamara G, Al KZ, Rosenthal J, Forman SJ, Jensen MC, Cooper LJ. Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posarcansplantation adoptive immunotherapy. Blood; 2006, 107(7): 2643-2652.
Wong JY, Liu A, Schultheiss T, Popplewell L, Stein A, Rosenthal J, Essensten M, Forman S, Somlo G. Targeted total marrow irradiation using three-dimensional image-guided tomographic intensity-modulated radiation therapy: An alternative to standard total body irradiation. Biology of Blood and Marrow Transplantation; 2006, 12(3): 306-315.
Wong JY, Chu DZ, Williams LE, Liu A, Zhan J, Yamauchi DM, Wilczynski S, Wu AM, Yazaki PJ, Shively JE, Leong L, Raubitschek AA. A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignancies. Cancer Biother Radiopharm; 2006, 21(2): 88-100.
Chen C, Lee WH, Zhong L, Liu CP. Regulatory T cells can mediate their function through the stimulation of APCs to produce immunosuppressive nitric oxide. J Immunol; 2006, 176(6): 3449-60.
Yam P, Jensen M, Akkina R, Anderson J, Villacres MC, Wu J, Zaia JA, Yee JK. Ex vivo selection and expansion of cells based on expression of a mutated inosine monophosphate dehydrogenase 2 after HIV vector transduction: effects on lymphocytes, monocytes, and CD34+ stem cells. Mol Ther; 2006, 14(2): 236-44.
Miale TD, Wong JY, Ahmed I, Wagman LD. Multimodal management, including precisely targeted irradiation, in a severe refractory case of Evans syndrome. Pediatr Blood Cancer; 2006, 47(5 Suppl): 726-8.
Pigazzi A, Ellenhorn JD, Ballantyne GH, Paz IB. Robotic-assisted laparoscopic low anterior resection with total mesorectal excision for rectal cancer. Surg Endosc; 2006, 20(10): 1521-5.
Wong JY. Basic immunology of antibody targeted radiotherapy. Int J Radiat Oncol Biol Phys; 2006, 66(2 Suppl): S8-14.
Wong JY. Systemic targeted radionuclide therapy: potential new areas. Int J Radiat Oncol Biol Phys; 2006, 66(2 Suppl): S74-82.
Chen S, Masri S, Hong Y, Wang X, Phung S, Yuan Y, Wu X. New experimental models for aromatase inhibitor resistance. In Press. J. Steroid Biochem & Mol Biol; 2006.
Chen S, Masri S, Wang X, Phung S, Yuan Y, Wu X. What do we know about the mechanisms of aromatase inhibitor resistance? In press. J. Steroid Biochem. & Mol. Biol; 2006.
Gu Z, Olafsen T, Sherman M, Leyton J, Witkosky M, Shively J, Raubitschek A, Morrison S, Wu A, Reiter R. Targeting, Imaging, and Therapy using a Humanized Anti-Prostate Stem Cell Antigen (PSCA) Antibody. In Press. Journal of Immunotherapy; 2006.
Hong Y, Yu B, Sherman M, Yuan Y, Zhou D, Chen S. Molecular basis for the aromatization reaction and irreversible inhibition of human aromatases by exemestance. In press. Mol. Endocrinol; 2006.
Wang X, Chen S. Aromatase destablizer: Novel action of exemestane, an FDA approved aromatase inhibitor. In press. Cancer Research; 2006.
Kaiser A, Schultheiss TE, Wong JY, Smith DD, Han C, Vora NL, Pezner RD, Chen YJ, Radany EH. Pitch, roll, and yaw variations in patient positioning. Int J Radiat Oncol Biol Phys; 2006, 66(3): 949-55.
Podnos YD, Tsai NC, Smith D, Ellenhorn JD. Factors affecting survival in patients with anal melanoma. Am Surg; 2006, 72(10): 917-20.